Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1573-7373

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma ; day:16 ; month:4 ; year:2018 ; pages:1-9
Journal of neuro-oncology ; (16.4.2018), 1-9

Creator: Wijnenga, Maarten M. J.

Contributor: French, Pim J.
Dubbink, Hendrikus J.
Dinjens, Winand N. M.
Atmodimedjo, Peggy N.
Kros, Johan M.
Fleischeuer, Ruth
Dirven, Clemens M. F.
Vincent, Arnaud J. P. E.
Van den Bent, Martin J.
SpringerLink (Online service)

DOI: 10.1007/s11060-018-2867-8

URN: urn:nbn:de:101:1-2018062023121805614525

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:22 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Wijnenga, Maarten M. J.
French, Pim J.
Dubbink, Hendrikus J.
Dinjens, Winand N. M.
Atmodimedjo, Peggy N.
Kros, Johan M.
Fleischeuer, Ruth
Dirven, Clemens M. F.
Vincent, Arnaud J. P. E.
Van den Bent, Martin J.
SpringerLink (Online service)

Other Objects (12)

Updates on the WHO diagnosis of IDH-mutant glioma

Treatment of IDH-mutant glioma in the INDIGO era

Hochschulschrift

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

Hochschulschrift

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma

A patient-derived cell model for malignant transformation in IDH-mutant glioma

Energy metabolism-related GLUD1 contributes to favorable clinical outcomes of IDH-mutant glioma

Therapies for IDH-Mutant Gliomas

PERK‐Mediated Cholesterol Excretion from IDH Mutant Glioma Determines Anti‐Tumoral Polarization of Microglia

Comprehensive analysis of the REST transcription factor regulatory networks in IDH mutant and IDH wild-type glioma cell lines and tumors

Mutant IDH and non-mutant chondrosarcomas display distinct cellular metabolomes

Stalled oligodendrocyte differentiation in IDH-mutant gliomas

Updates on the WHO diagnosis of IDH-mutant glioma

Treatment of IDH-mutant glioma in the INDIGO era

Hochschulschrift

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

Hochschulschrift

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma

A patient-derived cell model for malignant transformation in IDH-mutant glioma

Energy metabolism-related GLUD1 contributes to favorable clinical outcomes of IDH-mutant glioma

Therapies for IDH-Mutant Gliomas

PERK‐Mediated Cholesterol Excretion from IDH Mutant Glioma Determines Anti‐Tumoral Polarization of Microglia

Comprehensive analysis of the REST transcription factor regulatory networks in IDH mutant and IDH wild-type glioma cell lines and tumors

Mutant IDH and non-mutant chondrosarcomas display distinct cellular metabolomes

Stalled oligodendrocyte differentiation in IDH-mutant gliomas

Updates on the WHO diagnosis of IDH-mutant glioma

Treatment of IDH-mutant glioma in the INDIGO era

Hochschulschrift

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

Hochschulschrift

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma

A patient-derived cell model for malignant transformation in IDH-mutant glioma

Energy metabolism-related GLUD1 contributes to favorable clinical outcomes of IDH-mutant glioma

Therapies for IDH-Mutant Gliomas

PERK‐Mediated Cholesterol Excretion from IDH Mutant Glioma Determines Anti‐Tumoral Polarization of Microglia

Comprehensive analysis of the REST transcription factor regulatory networks in IDH mutant and IDH wild-type glioma cell lines and tumors

Mutant IDH and non-mutant chondrosarcomas display distinct cellular metabolomes

Stalled oligodendrocyte differentiation in IDH-mutant gliomas

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Updates on the WHO diagnosis of IDH-mutant glioma

Treatment of IDH-mutant glioma in the INDIGO era

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma

A patient-derived cell model for malignant transformation in IDH-mutant glioma

Energy metabolism-related GLUD1 contributes to favorable clinical outcomes of IDH-mutant glioma

Therapies for IDH-Mutant Gliomas

PERK‐Mediated Cholesterol Excretion from IDH Mutant Glioma Determines Anti‐Tumoral Polarization of Microglia

Comprehensive analysis of the REST transcription factor regulatory networks in IDH mutant and IDH wild-type glioma cell lines and tumors

Mutant IDH and non-mutant chondrosarcomas display distinct cellular metabolomes

Stalled oligodendrocyte differentiation in IDH-mutant gliomas

Updates on the WHO diagnosis of IDH-mutant glioma

Treatment of IDH-mutant glioma in the INDIGO era

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma

A patient-derived cell model for malignant transformation in IDH-mutant glioma

Energy metabolism-related GLUD1 contributes to favorable clinical outcomes of IDH-mutant glioma

Therapies for IDH-Mutant Gliomas

PERK‐Mediated Cholesterol Excretion from IDH Mutant Glioma Determines Anti‐Tumoral Polarization of Microglia

Comprehensive analysis of the REST transcription factor regulatory networks in IDH mutant and IDH wild-type glioma cell lines and tumors

Mutant IDH and non-mutant chondrosarcomas display distinct cellular metabolomes

Stalled oligodendrocyte differentiation in IDH-mutant gliomas

Updates on the WHO diagnosis of IDH-mutant glioma

Treatment of IDH-mutant glioma in the INDIGO era

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma

A patient-derived cell model for malignant transformation in IDH-mutant glioma

Energy metabolism-related GLUD1 contributes to favorable clinical outcomes of IDH-mutant glioma

Therapies for IDH-Mutant Gliomas

PERK‐Mediated Cholesterol Excretion from IDH Mutant Glioma Determines Anti‐Tumoral Polarization of Microglia

Comprehensive analysis of the REST transcription factor regulatory networks in IDH mutant and IDH wild-type glioma cell lines and tumors

Mutant IDH and non-mutant chondrosarcomas display distinct cellular metabolomes

Stalled oligodendrocyte differentiation in IDH-mutant gliomas

Related objects

Reset password